Effects of methyl benzimidazolecarbamate during early pregnancy in the rat

A M Cummings1, S T Harris, G L Rehnberg

  • 1Developmental Toxicology Division, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711.

Insights

Methyl 2-benzimidazolecarbamate (MBC) fungicide showed no maternal effects in early pregnancy at doses up to 400 mg/kg. Higher doses caused maternal toxicity and hormonal changes, impacting pregnancy outcomes.

Area of Science:

  • Toxicology
  • Reproductive Science
  • Developmental Biology

Background:

  • Methyl 2-benzimidazolecarbamate (MBC) and benomyl are agricultural fungicides.
  • Previous studies indicate adverse reproductive and embryotoxic effects in male and pregnant rats.

Purpose of the Study:

  • Assess maternal effects of MBC during early pregnancy.
  • Differentiate maternal toxicity from embryotoxicity.
  • Distinguish early pregnancy failure from late embryonic loss.

Main Methods:

  • Rats received MBC (0-1000 mg/kg/day) during Days 1-8 of pregnancy.
  • Maternal and embryonic parameters assessed on Day 9.
  • Pseudopregnant rats tested for uterine competency with MBC exposure.

Main Results:

  • No significant maternal or embryonic effects observed up to 400 mg/kg/day MBC.
  • 1000 mg/kg/day MBC reduced body weight gain, implantation site weight, and altered LH and estradiol levels.
  • MBC at 400 mg/kg/day partially reduced decidual growth in pseudopregnant rats.

Conclusions:

  • MBC does not appear to cause maternal toxicity or early pregnancy failure at doses below 1000 mg/kg/day.
  • High-dose MBC exposure can induce maternal toxicity and hormonal disturbances.
  • Uterine competency may be affected by MBC, warranting further investigation.